These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15791349)

  • 1. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment.
    Vellas B; Lauque S; Gillette-Guyonnet S; Andrieu S; Cortes F; Nourhashémi F; Cantet C; Ousset PJ; Grandjean H;
    J Nutr Health Aging; 2005; 9(2):75-80. PubMed ID: 15791349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group).
    Guerin O; Soto ME; Brocker P; Robert PH; Benoit M; Vellas B;
    J Nutr Health Aging; 2005; 9(2):81-4. PubMed ID: 15791350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohort.
    Gillette-Guyonnet S; Cortes F; Cantet C; Vellas B;
    J Nutr Health Aging; 2005; 9(2):69-73. PubMed ID: 15791348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
    Cortes F; Portet F; Touchon J; Vellas B
    J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.
    Cortes F; Nourhashémi F; Guérin O; Cantet C; Gillette-Guyonnet S; Andrieu S; Ousset PJ; Vellas B;
    Alzheimers Dement; 2008 Jan; 4(1):22-9. PubMed ID: 18631947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent data on the natural history of Alzheimer's disease: results from the REAL.FR Study.
    Cortes F; Gillette-Guyonnet S; Nourhashemi F; Andrieu S; Cantet C; Vellas B;
    J Nutr Health Aging; 2005; 9(2):86-93. PubMed ID: 15791351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
    Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
    J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease.
    Bartorelli L; Giraldi C; Saccardo M; Cammarata S; Bottini G; Fasanaro AM; Trequattrini A;
    Curr Med Res Opin; 2005 Nov; 21(11):1809-18. PubMed ID: 16307702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.
    Soto ME; Andrieu S; Cantet C; Reynish E; Ousset PJ; Arbus C; Gillette-Guyonnet S; Nourhashémi F; Vellas B;
    Dement Geriatr Cogn Disord; 2008; 26(2):109-16. PubMed ID: 18617740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease.
    Rivière S; Gillette-Guyonnet S; Voisin T; Reynish E; Andrieu S; Lauque S; Salva A; Frisoni G; Nourhashemi F; Micas M; Vellas B
    J Nutr Health Aging; 2001; 5(4):295-9. PubMed ID: 11753499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease.
    Feldman HH; Pirttila T; Dartigues JF; Everitt B; Van Baelen B; Schwalen S; Kavanagh S
    Int J Geriatr Psychiatry; 2009 May; 24(5):479-88. PubMed ID: 18985627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease.
    Wiig EH; Annas P; Basun H; Andreasen N; Lannfelt L; Zetterberg H; Blennow K; Minthon L
    Acta Neurol Scand; 2010 Mar; 121(3):186-93. PubMed ID: 19785641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.
    Lucchi E; Minicuci N; Magnifico F; Mondini S; Calza A; Avanzi S; Villani D; Bellelli G; Trabucchi M
    Arch Gerontol Geriatr Suppl; 2004; (9):253-63. PubMed ID: 15207422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the nutritional status of patients over 60-year admitted in a hematology department using the mininutritional assessment (MNA). A single centre study of 120 cases.
    Bauduer F; Scribans C; Dubernet E; Capdupuy C
    J Nutr Health Aging; 2003; 7(3):179-82. PubMed ID: 12766796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.
    Lopez OL; Becker JT; Saxton J; Sweet RA; Klunk W; DeKosky ST
    J Am Geriatr Soc; 2005 Jan; 53(1):83-7. PubMed ID: 15667381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living alone with Alzheimer's disease: cross-sectional and longitudinal analysis in the REAL.FR Study.
    Nourhashemi F; Amouyal-Barkate K; Gillette-Guyonnet S; Cantet C; Vellas B;
    J Nutr Health Aging; 2005; 9(2):117-20. PubMed ID: 15791356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results.
    Gillette-Guyonnet S; Nourhashemi F; Andrieu S; Cantet C; Micas M; Ousset PJ; Vellas B;
    J Nutr Health Aging; 2003; 7(2):91-6. PubMed ID: 12679828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A six months' prospective follow-up of 65+-y-old patients from general practice classified according to nutritional risk by the Mini Nutritional Assessment.
    Beck AM; Ovesen L; Schroll M
    Eur J Clin Nutr; 2001 Nov; 55(11):1028-33. PubMed ID: 11641754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional risk factors for institutional placement in Alzheimer's disease after one year follow-up.
    Andrieu S; Reynish W; Nourhashemi F; Ousset PJ; Grandjean H; Grand A; Albarede JL; Vellas B
    J Nutr Health Aging; 2001; 5(2):113-7. PubMed ID: 11426292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective pilot study on the development of cognitive, behavioral and functional disorders in a sample of patients with early dementia of Alzheimer type.
    Coin A; Najjar M; Catanzaro S; Orru G; Sampietro S; Sergi G; Manzato E; Perissinotto E; Rinaldi G; Sarti S; Imoscopi A; Ruggiero E; Girardi A
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():35-8. PubMed ID: 19836614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.